Skip to content

Observation of the efficacy of sequential magnetic stimulation on patients with swallowing dysfunction after brainstem stroke

Observation of the efficacy of sequential magnetic stimulation on patients with swallowing dysfunction after brainstem stroke

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114450
Enrollment
Unknown
Registered
2025-12-11
Start date
2025-04-28
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brainstem Stroke

Interventions

Sequential Magnetic Stimulation Group:Repetitive Transcranial Magnetic Stimulation Combined with Repetitive Peripheral Magnetic Stimulation Therapy
Repetitive Peripheral Magnetic Stimulation Group:Repetitive Peripheral Magnetic Stimulation Therapy

Sponsors

Guangdong Sanjiu Brain Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: English Translation: 1. Diagnostic Criteria: Stroke diagnosis complied with the 2014 Chinese Guidelines for the Diagnosis and Treatment of Cerebral Hemorrhage or the 2018 Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke. 2. Inclusion Criteria: a. Met the diagnostic criteria with cranial MRI-confirmed brainstem lesions; b. Aged 18–65 years; c. Clinically stable, without impaired consciousness, and able to cooperate with examinations and treatment; d. Disease duration of 1–3 months; e. Swallowing function assessed as Grade 3 or above (e.g., using the Functional Oral Intake Scale [FOIS]); f. Detectable motor evoked potentials (MEPs); g. No prior history of stroke and signed informed consent.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: a. Patients with skull defects; b. History of epilepsy, idiopathic epilepsy in first-degree relatives, or use of epileptogenic drugs; c. Severe hepatic/renal diseases, cardiovascular diseases, hematological disorders, malignant tumors, etc.; d. Pregnant and lactating patients; e. Patients unable to control head movement or with tremors; f. Patients with implanted metal devices in the body, such as intracranial metal electrodes or cardiac pacemakers; g. Patients with an increased risk of inducing seizures; h. Patients with increased intracranial pressure; i. Patients in the acute phase of intracranial hemorrhage; j. Patients who refuse or do not cooperate with treatment.

Design outcomes

Primary

MeasureTime frame
Motor Evoked Potentials Testing;High-Resolution Pharyngeal Manometry ;Kubota Water Swallowing Test;Saito Dysphagia Severity Scale;Fujishima Ichiro Swallowing Method ;

Countries

China

Contacts

Public ContactWeifeng Wen

Guangdong Sanjiu Brain Hospital

tianshizhiyi05@163.com+86 135 7096 0328

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026